跳至主要内容
临床试验/JPRN-jRCT1061230099
JPRN-jRCT1061230099招募中4 期

comparison of short term efficacy of pain and QOL between romosozumab and risedronate against osteoporotic vertebral fractures

Tetsunaga Tomoko0 个研究点目标入组 60 人开始时间: 2024年2月7日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Patients with vertebral fracture with vertebral body compression on X-ray and with vertebral body signal sntensity change on MRI.
  • 2)Patients with osteoporosis with high risk of oste oporotic fractures.
  • 3)Patients with more than 5 score of NRS(Numerical Rating Scale) at first visiting
  • 4)Patients aged 50 years or older at the time of consect acquisition.
  • 5)Patients who received sufficient explanation before participating in this study, and obtained the patient's free will to consent to the document after sufficient understanding.
  • 6)Inpatients and outpatients

排除标准

  • 1)Patients under treatment for osteoporosis at the time of injury.
  • 2)Patients due to high energy trauma.
  • 3)patients with severe kidney disease(eGFR<30).
  • 4)Patients with hypocalcemia
  • 5)Patients who cannot answer the questionnaire due to dementia
  • 6)Patients who need invasive dental treatment
  • 7)Patients who are judged by the principal investigator and the research coordinator to be
  • inappropriate as research subjects

研究者

发起方
Tetsunaga Tomoko

相似试验